Table 1.
Parameters | Patients (n = 176) |
---|---|
Age (years) | 51.2 (10.6) |
Weight (kg) | 100.2 (21.5) |
BMI (kg/m2) | 36.4 (7.1) |
Sex | |
Female | 121 (69%) |
Male | 55 (31%) |
Race | |
Asian | 3 (2%) |
Black | 2 (1%) |
White | 166 (94%) |
Other | 5 (3%) |
Ethnicity | |
Hispanic/Latino | 82 (47%) |
Non‐Hispanic/Latino | 94 (53%) |
Type 2 diabetes | |
Yes | 87 (49%) |
No | 89 (51%) |
Histology | |
Fibrosis stage | |
1 | 62 (35%) |
2 | 56 (32%) |
3 | 56 (32%) |
4 | 2 (1%) |
Total NAS score | 5.3 (1.2) |
Ballooning | |
0 (none) | 6 (3%) |
1 (few ballooned cells) | 85 (48%) |
2 (many ballooned cells) | 84 (48%) |
Steatosis | |
0 (<5%) | 0 |
1 (5%‐33%) | 40 (23%) |
2 (34%‐66%) | 76 (43%) |
3 (>66%) | 59 (34%) |
Inflammation | |
0 (none) | 0 |
1 (<2) | 59 (34%) |
2 (2‐4) | 100 (57%) |
3 (>4) | 16 (9%) |
LFC by MRI‐PDFF | |
LFC (%) | 18.6 (6.8) |
Note: Values are presented as mean (SD) or n (%). Percentages may not total 100 because of rounding.
Abbreviations: BMI, body mass index; NAS, nonalcoholic fatty liver disease activity score.